登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 84016 条符合本次的查询结果， 用时 5.9287951 秒

1981. DoxyPEP Shows Promise for Reducing STIs in 2 Studies.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷9期746页

1982. Bird Flu Case Analysis Calls for Balancing Heightened Vigilance and Routine Practice.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷9期746页

1983. What Does the Rise of GLP-1 Drugs Mean for Bariatric Surgery?

作者: Kate Schweitzer.
来源: JAMA. 2025年333卷9期743-745页

1984. Patient Messaging Declines After E-Billing, but Clinician Workload Persists.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷9期746-747页

1985. How Should Health Care and Public Health Respond to the New US Administration?

作者: Steven H Woolf.
来源: JAMA. 2025年333卷14期1197-1198页

1986. Sweetened Beverages Linked to Millions of Global Diabetes and Heart Disease Cases.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷9期747页

1987. Study Finds People Prefer AI Over Clinician Responses to Questions in the Electronic Medical Record.

作者: Roy Perlis.;Nora Collins.
来源: JAMA. 2025年333卷9期738-740页

1988. CDC Advises Expedited Influenza Subtyping in Hospitalized Patients to Help Identify Bird Flu Cases Sooner.

作者: Anna Bock.
来源: JAMA. 2025年333卷9期741-742页

1989. Evolocumab Achieves Low LDL Cholesterol Without Long-Term Cognitive Risks.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷9期747页

1990. Toward a Unified Vision for US Biomedical Research.

作者: E Albert Reece.;Victor J Dzau.
来源: JAMA. 2025年333卷14期1199-1200页

1991. Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery.

作者: Ori J Lieberman.;Sara C LaHue.
来源: JAMA. 2025年333卷8期722-723页

1992. Remains.

作者: Janice Lynch Schuster.
来源: JAMA. 2025年333卷8期727页

1993. Molecular Phenotyping With Proteomics.

作者: Devin K Schweppe.;Brian J Beliveau.;Andrew N Hoofnagle.
来源: JAMA. 2025年333卷10期898-899页

1994. Where Did the Passion Go?-Rethinking Adjuvant Immune Therapy for Triple-Negative Breast Cancer.

作者: Natasha Hunter.;Sara Hurvitz.
来源: JAMA. 2025年

1995. Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery-Reply.

作者: Xosé Pérez-Fernández.;Arnau Ulsamer.;Joan Sabater-Riera.
来源: JAMA. 2025年333卷8期723页

1996. Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial.

作者: Michail Ignatiadis.;Andrew Bailey.;Heather McArthur.;Sarra El-Abed.;Evandro de Azambuja.;Otto Metzger.;Stephen Y Chui.;Max Dieterich.;Thomas Perretti.;Esther Shearer-Kang.;Luciana Molinero.;Günther G Steger.;Jacek Jassem.;Soo Chin Lee.;Michaela Higgins.;Jose Zarba.;Marcus Schmidt.;Henry Gomez.;Angel Guerrero Zotano.;Luca Moscetti.;Joanne Chiu.;Elisabetta Munzone.;Noa Efrat Ben-Baruch.;Emilio Bajetta.;Shinji Ohno.;Seock-Ah Im.;Gustavo Werutsky.;Einav Nili Gal-Yam.;Xavier Gonzalez Farre.;Ling-Ming Tseng.;William Jacot.;Oleg Gluz.;Zhimin Shao.;Yaroslav Shparyk.;Anastasia Zimina.;Eric Winer.;David A Cameron.;Giuseppe Viale.;Shigehira Saji.;Richard Gelber.;Martine Piccart.
来源: JAMA. 2025年333卷13期1150-60页
Triple-negative breast cancer is an aggressive subtype with a high incidence in young patients, a high incidence in non-Hispanic Black women, and a high risk of progression to metastatic cancer, a devastating sequela with a 12- to 18-month life expectancy. Until recently, one strategy for treating early-stage triple-negative breast cancer was chemotherapy after surgery. However, it was not known whether the addition of immune therapy to postsurgery chemotherapy would be beneficial.

1997. Match Day.

作者: Cerrone Cohen.
来源: JAMA. 2025年333卷8期669页

1998. The University and the Library: A Study in Ecology.

来源: JAMA. 2025年333卷8期728页

1999. Removing Ineffective Drugs From the Market: Implications for Oral Phenylephrine and Beyond.

作者: Sarah Tanveer.;John P A Ioannidis.
来源: JAMA. 2025年333卷11期937-938页

2000. What Are Bedbugs?

作者: Rebecca Voelker.
来源: JAMA. 2025年333卷8期732页
共有 84016 条符合本次的查询结果， 用时 5.9287951 秒